Antituberculosis Treatment in a Patient with Celiac Disease
Arch Bronconeumol (Engl Ed). 2018 Jun;54(6):337-338.
doi: 10.1016/j.arbres.2017.12.009.
Epub 2018 Feb 14.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, España.
- 2 Servicio de Neumología, Hospital General de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, España.
- 3 Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, España. Electronic address: javier.miguel@salud.madrid.org.
No abstract available
MeSH terms
-
Aged
-
Antitubercular Agents / adverse effects
-
Antitubercular Agents / therapeutic use*
-
Celiac Disease / complications*
-
Celiac Disease / diet therapy
-
Diarrhea / chemically induced
-
Diarrhea / etiology
-
Diet, Gluten-Free
-
Drug Compounding
-
Drug Substitution
-
Drug Therapy, Combination
-
Ethambutol / therapeutic use
-
Glutens
-
Hemoptysis / etiology
-
Humans
-
Isoniazid / adverse effects*
-
Isoniazid / therapeutic use
-
Male
-
Metronidazole / therapeutic use
-
Moxifloxacin / therapeutic use
-
Pyrazinamide / therapeutic use
-
Rifampin / therapeutic use
-
Smoking / adverse effects
-
Tomography, X-Ray Computed
-
Tuberculosis, Pulmonary / complications
-
Tuberculosis, Pulmonary / drug therapy*
Substances
-
Antitubercular Agents
-
Metronidazole
-
Pyrazinamide
-
Glutens
-
Ethambutol
-
Moxifloxacin
-
Isoniazid
-
Rifampin